{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T23:10:27Z","timestamp":1781478627319,"version":"3.54.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,5,10]],"date-time":"2008-05-10T00:00:00Z","timestamp":1210377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s00404-007-0497-z","type":"journal-article","created":{"date-parts":[[2008,5,9]],"date-time":"2008-05-09T12:06:01Z","timestamp":1210334761000},"page":"1-12","source":"Crossref","is-referenced-by-count":25,"title":["Depot-medroxyprogesterone acetate: an update"],"prefix":"10.1007","volume":"278","author":[{"given":"Sayed","family":"Bakry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaher O.","family":"Merhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trudy J.","family":"Scalise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad S.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Fadiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Naftolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,10]]},"reference":[{"key":"497_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00257410","volume":"11","author":"CM Camaggi","year":"1983","unstructured":"Camaggi CM, Strocchi E, Giovannini M (1983) Medroxyprogesterone acetate (MAP) plasma levels after multiple high-dose administrations in advanced cancer patients. Cancer Chemother Pharmacol 11:19\u201322","journal-title":"Cancer Chemother Pharmacol"},{"key":"497_CR2","first-page":"435","volume":"2","author":"CE Wright","year":"1983","unstructured":"Wright CE, Antal EJ, Gillespie WR (1983) Effect of injection volume on the bioavailability of sterile Medroxyprogesterone acetate suspension. Clin Pharm 2:435\u2013438","journal-title":"Clin Pharm"},{"key":"497_CR3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00292875","volume":"8","author":"HC Blossey","year":"1982","unstructured":"Blossey HC, Bartsch HH, Kanne D (1982) The pharmacokinetics of high-dose Medroxyprogesterone acetate (MPA) in the therapy of advanced breast cancer. Cancer Chemother Pharmacol 8:77\u201381","journal-title":"Cancer Chemother Pharmacol"},{"key":"497_CR4","volume-title":"Clinical gynecologic endocrinology and infertility","author":"L Speroff","year":"1989","unstructured":"Speroff L, Glass RH, Kase NG (1989) Clinical gynecologic endocrinology and infertility. 4th ed. Williams & Wilkins, Baltimore, MD","edition":"4th ed."},{"key":"497_CR5","first-page":"1397","volume-title":"Goodman and Gilman\u2019s the pharmacological basis of therapeutics","author":"A Goodman-Gilman","year":"1990","unstructured":"Goodman-Gilman A, Rall TW, Nies AS (1990) Goodman and Gilman\u2019s the pharmacological basis of therapeutics. 8th ed. Pergamon, New York, NY, pp 1397\u20131401","edition":"8th ed."},{"key":"497_CR6","volume-title":"Contraceptive technology 1990\u20131992","author":"RA Hatcher","year":"1990","unstructured":"Hatcher RA, Stewart F, Trussell J (1990) Contraceptive technology 1990\u20131992. 15th ed. Irvington, New York, NY","edition":"15th ed."},{"key":"497_CR7","volume-title":"A clinical guide for contraception","author":"L Speroff","year":"1992","unstructured":"Speroff L, Darney PD (1992) A clinical guide for contraception. Williams & Wilkins, Baltimore, MD"},{"key":"497_CR8","volume-title":"Depo-Provera(R), medroxyprogesterone","author":"Product Information","year":"1998","unstructured":"Product Information (1998) Depo-Provera(R), medroxyprogesterone. The Upjohn Company, Kalamazoo, MI"},{"key":"497_CR9","volume-title":"Premphase (R), conjugated estrogens\/medroxyprogesterone acetate","author":"Product Information","year":"1999","unstructured":"Product Information (1999) Premphase (R), conjugated estrogens\/medroxyprogesterone acetate. Wyeth Ayerst Laboratories, Philadelphia, PA"},{"key":"497_CR10","first-page":"229","volume":"2","author":"K Di Celser","year":"1982","unstructured":"Di Celser K, Gruber C, Hayes C (1982) Medroxyprogesterone acetate and homozygous sickle-cell disease. Lancet 2:229\u2013232","journal-title":"Lancet"},{"key":"497_CR11","first-page":"596","volume":"62","author":"M Notelovitz","year":"1983","unstructured":"Notelovitz M, Kitchens G, Ware M (1983) Combination estrogen and progestogen replacement therapy does not adversely affect coagulation. Obstet Gynecol 62:596\u2013600","journal-title":"Obstet Gynecol"},{"key":"497_CR12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5694\/j.1326-5377.1984.tb104038.x","volume":"140","author":"J Roche","year":"1984","unstructured":"Roche J (1984) Steroid-induced arachnoiditis. Med J Aust 140:281\u2013284","journal-title":"Med J Aust"},{"key":"497_CR13","first-page":"93","volume":"78","author":"C Kirkham","year":"1991","unstructured":"Kirkham C, Hahn PM, Van Vugt DA (1991) A randomized, double-blind, placebo-controlled, cross-over trial to asses the side effect of medroxyprogesterone acetate in hormone replacement therapy. Obstet Gynecol 78:93\u201397","journal-title":"Obstet Gynecol"},{"key":"497_CR14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0002-9378(16)33643-2","volume":"118","author":"E Guiloff","year":"1974","unstructured":"Guiloff E, Ibarra-Polo A, Zanartu J (1974) Effect of contraception on lactation. Am J Obstet Gynecol 118:42\u201345","journal-title":"Am J Obstet Gynecol"},{"key":"497_CR15","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1067\/mob.2002.123738","volume":"186","author":"LD Halderman","year":"2002","unstructured":"Halderman LD, Nelson AL (2002) Impact of early postpartum administration of progestin-only hormonal contraceptives compared with nonhormonal contraceptives on short-term breast-feeding patterns. Am J Obstet Gynecol 186:1250\u20131256","journal-title":"Am J Obstet Gynecol"},{"key":"497_CR16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0010-7824(80)90087-6","volume":"22","author":"K Amatayakul","year":"1980","unstructured":"Amatayakul K, Sivasomboon B, Thanangkul O (1980) A study of the mechanism of weight gain in medroxyprogesterone acetate users. Contraception 22:605\u2013622","journal-title":"Contraception"},{"key":"497_CR17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0010-7824(95)00189-H","volume":"52","author":"LL Moore","year":"1995","unstructured":"Moore LL, Valuck R, McDougall C, Fink W (1995) A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives. Contraception 52:215\u2013219","journal-title":"Contraception"},{"key":"497_CR18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1006616617242","volume":"14","author":"L Bahamondes","year":"1998","unstructured":"Bahamondes L, Diaz J, Petta C, Hall P (1998) Weight variation in users of the once-a-month injectable contraceptive cyclofem. Adv Contracept 14:223\u2013230","journal-title":"Adv Contracept"},{"key":"497_CR19","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0002-9378(12)91813-X","volume":"170","author":"AM Kaunitz","year":"1999","unstructured":"Kaunitz AM (1999) Long-acting injectable contraception with depot medroxyprogesterone acetate. Am J Obstet Gynecol 170:1543\u20131549","journal-title":"Am J Obstet Gynecol"},{"key":"497_CR20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1054-139X(98)00151-7","volume":"24","author":"WL Risser","year":"1999","unstructured":"Risser WL, Gefter LR, Barratt MS, Risser JM (1999) Weight change in adolescents who used hormonal contraception. Adolesc Health 24:433\u2013436","journal-title":"Adolesc Health"},{"key":"497_CR21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0010-7824(00)00144-X","volume":"62","author":"E Espey","year":"2000","unstructured":"Espey E, Steinhart J, Ogburn T, Qualls C (2000) Depo-Provera associated with weight gain in Navajo women. Contraception 62:55\u201358","journal-title":"Contraception"},{"key":"497_CR22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0010-7824(01)00255-4","volume":"64","author":"L Bahamondes","year":"2001","unstructured":"Bahamondes L, Del-Castillo S, Tabares G, Arce XE, Perrotti M, Petta C (2001) Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5\u00a0years. Contraception 64:223\u2013225","journal-title":"Contraception"},{"key":"497_CR23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1083-3188(01)00147-4","volume":"15","author":"SA Mangan","year":"2002","unstructured":"Mangan SA, Larsen PG, Hudson S (2002) Overweight teens at increased risk for weight gain while using depot medroxyprogesteroneacetate. J Pediatr Adolesc Gynecol 15:79\u201382","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"497_CR24","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0026-0495(03)00181-1","volume":"52","author":"MK Shadoan","year":"2003","unstructured":"Shadoan MK, Anthony MS, Rankin SE, Clarkson TB, Wagner JD (2003) Effects of tibolone and conjugated equine estrogens with or without medroxyprogesterone acetate on body composition and fasting carbohydrate measures in surgically postmenopausal monkeys. Metabolism 52:1085\u20131089","journal-title":"Metabolism"},{"key":"497_CR25","first-page":"30","volume":"13","author":"AR Mia","year":"2004","unstructured":"Mia AR, Siddiqui NI, Khan MR, Shampa SS, Rukunuzzaman, Akhter M, Kamrunnaher (2004) Effect of prolonged use of injectable hormonal contraceptives on blood pressure and body weight. Mymensingh Med J 13:30\u201332","journal-title":"Mymensingh Med J"},{"key":"497_CR26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2106\/00004623-197557050-00014","volume":"57","author":"NF Goldsmith","year":"1975","unstructured":"Goldsmith NF, Johnston JO (1975) Bone mineral: effects of oral contraceptives, pregnancy, and lactation. J Bone Joint Surg Am 57:657\u2013668","journal-title":"J Bone Joint Surg Am"},{"key":"497_CR27","first-page":"569","volume":"92","author":"T Cundy","year":"1998","unstructured":"Cundy T, Cornish J, Roberts H, Elder H, Reid IR (1998) Spinal bone density in women using depot medroxyprogesterone contraception. Obstet Gynecol 92:569\u2013573","journal-title":"Obstet Gynecol"},{"key":"497_CR28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1365-2265.1998.00582.x","volume":"49","author":"BJ Orr-Walker","year":"1998","unstructured":"Orr-Walker BJ, Evans MC, Ames RW, Clearwater JM, Cundy T, Reid IR (1998) The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women. Clin Endocrinol (Oxf) 49:615\u2013618","journal-title":"Clin Endocrinol (Oxf)"},{"key":"497_CR29","first-page":"233","volume":"93","author":"D Scholes","year":"1999","unstructured":"Scholes D, LaCroix AZ, Ott SM, Ichikawa LE, Barlow WE (1999) Bone mineral density in women using depot medroxyprogesterone acetate for contraception. Obstet Gynecol 93:233\u2013238","journal-title":"Obstet Gynecol"},{"key":"497_CR30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0010-7824(00)00168-2","volume":"62","author":"OS Tong","year":"2000","unstructured":"Tong OS, Tang G, Yip PS, Li B (2000) Further evaluation on long-term depot-medroxyprogesterone acetate use and bone mineral density: a longitudinal cohort study. Contraception 62:161\u2013164","journal-title":"Contraception"},{"key":"497_CR31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM199607043350102","volume":"335","author":"DB Petitti","year":"1996","unstructured":"Petitti DB, Sidney S, Bernstein A, Wolf S, Quesenberry C, Ziel HK (1996) Stroke in users of low-dose oral contraceptives. N Engl J Med 335:8\u201315","journal-title":"N Engl J Med"},{"key":"497_CR32","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/01.AOG.0000117082.49490.d5","volume":"103","author":"AB Berenson","year":"2001","unstructured":"Berenson AB, Breitkopf CR, Grady JJ, Rickert VI, Thomas A (2001) Effects of hormonal contraception on bone mineral density after 24\u00a0months of use. Obstet Gynecol 103:899\u2013906","journal-title":"Obstet Gynecol"},{"key":"497_CR33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00001648-200209000-00015","volume":"13","author":"D Scholes","year":"2002","unstructured":"Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM (2002) Injectable hormone contraception and bone density: results from a prospective study. Epidemiology 13:581\u2013587","journal-title":"Epidemiology"},{"key":"497_CR34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1054-139X(02)00567-0","volume":"32","author":"NH Busen","year":"2003","unstructured":"Busen NH, Britt RB, Rianon N (2003) Bone mineral density in a cohort of adolescent women using depot medroxyprogesterone acetate for one to two years. J Adolesc Health 32:257\u2013259","journal-title":"J Adolesc Health"},{"key":"497_CR35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpag.2003.11.017","volume":"17","author":"E Lara-Torre","year":"2004","unstructured":"Lara-Torre E, Edwards CP, Perlman S, Hertweck SP (2004) Bone mineral density in adolescent females using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol 17:17\u201321","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"497_CR36","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ajog.2004.12.067","volume":"192","author":"JH Liu","year":"2005","unstructured":"Liu JH, Muse KN (2005) The effects of progestins on bone density and bone metabolism in postmenopausal women: a randomized controlled trial. Am J Obstet Gynecol 192:1316\u20131323","journal-title":"Am J Obstet Gynecol"},{"key":"497_CR37","first-page":"419","volume":"41","author":"AM Kaunitz","year":"1996","unstructured":"Kaunitz AM (1996) Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer. J Reprod Med 41:419\u2013427","journal-title":"J Reprod Med"},{"key":"497_CR38","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/(SICI)1097-0142(19981225)84:6<328::AID-CNCR3>3.0.CO;2-Z","volume":"25","author":"PT Valente","year":"1998","unstructured":"Valente PT, Schantz HD, Trabal JF (1998) Cytologic changes in cervical smears associated with prolonged use of depot-medroxyprogesterone acetate. Cancer 25:328\u2013334","journal-title":"Cancer"},{"key":"497_CR39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0010-7824(94)90037-X","volume":"49","author":"A Jordan","year":"1994","unstructured":"Jordan A (1994) Toxicology of depot medroxyprogesterone acetate. Contraception 49:189\u2013201","journal-title":"Contraception"},{"key":"497_CR40","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","volume":"25","author":"K Ushijima","year":"2007","unstructured":"Ushijima K, Yahata H, Yoshikawa H, Konishi I, Yasugi T, Saito T et al (2007) Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol 25:2798\u20132803","journal-title":"J Clin Oncol"},{"key":"497_CR41","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/bdra.20184","volume":"73","author":"RL Brent","year":"2005","unstructured":"Brent RL (2005) Nongenital malformations following exposure to progestational drugs: the last chapter of an erroneous allegation. Birth Defects Res A Clin Mol Teratol 73:906\u2013918","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"497_CR42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/096721099300100413","volume":"1","author":"E Eel-Gindi","year":"1993","unstructured":"Eel-Gindi E, Ahmed-Nasr M (1993) Hormonal versus genetic factors in limb and heart anomalies. Cardiovasc Surg 1:381\u2013383","journal-title":"Cardiovasc Surg"},{"key":"497_CR43","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/jama.1960.03020100036007","volume":"172","author":"L Wilkins","year":"1960","unstructured":"Wilkins L (1960) Masculinization of female fetus due to use of orally given progestins. JAMA 172:1028\u20131032","journal-title":"JAMA"},{"key":"497_CR44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/216083a0","volume":"216","author":"I Gal","year":"1967","unstructured":"Gal I (1967) Hormonal pregnancy tests and congenital malformation. Nature 216:83","journal-title":"Nature"},{"key":"497_CR45","first-page":"1","volume":"suppl 203","author":"D Aarskog","year":"1970","unstructured":"Aarskog D )1970) Clinical and cytogenetic studies in hypospadias. Acta Paediatr Scand (suppl 203):1\u201362","journal-title":"Acta Paediatr Scand"},{"key":"497_CR46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1056\/NEJM197701132960202","volume":"296","author":"OP Heinonen","year":"1977","unstructured":"Heinonen OP (1977) Cardiovascular birth defects and antenatal exposure to female sex hormones. N Engl J Med 296:67\u201370","journal-title":"N Engl J Med"},{"key":"497_CR47","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0140-6736(77)90927-8","volume":"II","author":"IF Roberts","year":"1977","unstructured":"Roberts IF, West RJ (1977) Teratogenesis and maternal progesterone. Lancet II:982","journal-title":"Lancet"},{"key":"497_CR48","first-page":"315","volume":"224","author":"ANW Evans","year":"1980","unstructured":"Evans ANW (1980) The ingestion by pregnant women of substances toxic to the foetus. Practitioner 224:315\u2013319","journal-title":"Practitioner"},{"key":"497_CR49","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(83)90616-5","volume":"II","author":"JR Mann","year":"1983","unstructured":"Mann JR (1983) Transplacental carcinogenesis (adrenocortical carcinoma) associated with hydroxyprogesterone hexanoate. Lancet II:580","journal-title":"Lancet"},{"key":"497_CR50","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0015-0282(16)42729-9","volume":"28","author":"LM Ambani","year":"1977","unstructured":"Ambani LM, Joshi NJ, Vaidya RA, Devi PK (1977) Are hormonal contraceptives teratogenic? Fertil Steril 28:791\u2013797","journal-title":"Fertil Steril"},{"key":"497_CR51","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/ije\/7.4.309","volume":"7","author":"MB Bracken","year":"1978","unstructured":"Bracken MB, Holford TR, White C, Kelsey JL (1978) Role of oral contraception in congenital malformations of offspring. Int J Epidemiol 7:309\u2013317","journal-title":"Int J Epidemiol"},{"key":"497_CR52","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0010-7824(79)90062-3","volume":"19","author":"SK Saksena","year":"1979","unstructured":"Saksena SK, Salmonsen R, Lau IF (1979) Termination of pregnancy in the rat by RMI 12,936. Contraception 19:481\u2013488","journal-title":"Contraception"},{"key":"497_CR53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0161-4630(80)90044-0","volume":"4","author":"IF Lau","year":"1980","unstructured":"Lau IF, Hoogasian J, Wong SK, Saksena SK (1980) Effects of prostaglandin F2 alpha and an antiprogestational steroid, RMI 12,936, on rat pregnancy. Prostaglandins Med 4:121\u2013132","journal-title":"Prostaglandins Med"},{"key":"497_CR54","unstructured":"Nora JJ, Nora AH, Blu J, Ingram J, Fountain A, Peterson M, Lortscher RH, Kimberling WJ (1980) Exogenous progestogen and estrogen implicated in birth defects. IARC Sci Publ, pp 169\u2013178"},{"key":"497_CR55","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0002-9378(81)90227-1","volume":"1","author":"E Savolainen","year":"1981","unstructured":"Savolainen E, Saksela E, Saxen L (1981) Teratogenic hazards of oral contraceptives analyzed in a national malformation register. Am J Obstet Gynecol 1:521\u2013524","journal-title":"Am J Obstet Gynecol"},{"key":"497_CR56","first-page":"45","volume":"37","author":"MV Starkov","year":"1975","unstructured":"Starkov MV, Shashkina LF, Remezova MI (1975) A morphohistochemical study of the embryotropic action of steroids with androgenic properties. Arkh Patol 37:45\u201350","journal-title":"Arkh Patol"},{"key":"497_CR57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/tera.1420250106","volume":"25","author":"PL Rands","year":"1982","unstructured":"Rands PL, White RD, Carter MW, Allen SD, Bradshaw WS (1982) Indicators of developmental toxicity following prenatal administration of hormonally active compounds in the rat. I. Gestational length. Teratology 25:37\u201343","journal-title":"Teratology"},{"key":"497_CR58","first-page":"288","volume":"22","author":"HG Eibs","year":"1982","unstructured":"Eibs HG, Spielmann H, Hagele M (1982a) Teratogenic effects of progestin treatment during the pre- and postimplantation period of mouse embryos. Teratology 22:288\u2013289","journal-title":"Teratology"},{"key":"497_CR59","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/tera.1420250305","volume":"25","author":"HG Eibs","year":"1982","unstructured":"Eibs HG, Spielmann H, Jacob-Muller U, Klose J (1982b) Teratogenic effects of cyproterone acetate and medroxyprogesterone treatment during the pre- and postimplantation period of mouse embryos. II. Cyproterone acetate and medroxyprogesterone acetate treatment before implantation in vivo and in vitro. Teratology 25:291\u2013299","journal-title":"Teratology"},{"key":"497_CR60","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/0002-9378(86)90352-2","volume":"155","author":"A Kricker","year":"1986","unstructured":"Kricker A, Elliott JW, Forrest JM, McCredie J (1986) Congenital limb reduction deformities and use of oral contraceptives. Am J Obstet Gynecol 155:1072\u20131078","journal-title":"Am J Obstet Gynecol"},{"key":"497_CR61","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/tera.1420380206","volume":"38","author":"JL Yovich","year":"1988","unstructured":"Yovich JL, Turner SR, Draper R (1988) Medroxyprogesterone acetate therapy in early pregnancy has no apparent fetal effects. Teratology 38:135\u2013144","journal-title":"Teratology"},{"key":"497_CR62","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00006254-198906000-00008","volume":"44","author":"JL Yovich","year":"1989","unstructured":"Yovich JL, Turner SR, Draper R (1989) Medroxyprogesterone acetate therapy in early pregnancy has no apparent fetal effects. Obstet Gynecol Surv 44:447\u2013449","journal-title":"Obstet Gynecol Surv"},{"key":"497_CR63","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0010-7824(92)90053-V","volume":"45","author":"T Pardthaisong","year":"1992","unstructured":"Pardthaisong T, Yenchit C, Gray R (1992) The long-term growth and development of children exposed to Depo-Provera during pregnancy or lactation. Contraception 45:313\u2013324","journal-title":"Contraception"},{"key":"497_CR64","first-page":"24","volume":"12","author":"Anon","year":"1982","unstructured":"Anon (1982) Pregnancy categories for prescription drugs. FDA Drug Bull 12:24\u201325","journal-title":"FDA Drug Bull"},{"key":"497_CR65","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng0795-330","volume":"10","author":"MD Briggs","year":"1995","unstructured":"Briggs MD, Hoffman SM, King LM, Olsen AS, Mohrenweiser H, Leroy JG, Mortier GR, Rimoin DL, Lachman RS, Gaines ES et al (1995) Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet 10:330\u2013336","journal-title":"Nat Genet"},{"key":"497_CR66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0010-7824(02)00340-2","volume":"66","author":"L Borgatta","year":"2002","unstructured":"Borgatta L, Murthy A, Chuang C, Beardsley L, Burnhill MS (2002) Pregnancies diagnosed during Depo-Provera use. Contraception 66:169\u2013172","journal-title":"Contraception"},{"key":"497_CR67","first-page":"746","volume":"172","author":"E Wooltorton","year":"2005","unstructured":"Wooltorton E (2005) Medroxyprogesterone acetate (Depo-Provera) and bone mineral density loss. J Ayub Med Coll Abbottabad 172:746","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"497_CR68","unstructured":"FDA (2005) Depo-Provera (medroxyprogesterone acetate injectable suspension) revised product monograph, Pfizer. Available: http:\/\/www.fda.gov\/medwatch\/SAFETY\/2004\/safety04.htm#Depo (click on: November 2004\u2014Label\u2014Pfizer) (Accessed 8 Feb 2005)"},{"key":"497_CR69","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00317979","volume":"52","author":"E Sannes","year":"1983","unstructured":"Sannes E, Lyngset A, Nafstad I (1983) Teratogenicity and embryotoxicity of orally administered lynestrenol in rabbits. Arch Toxicol 52:23\u201333","journal-title":"Arch Toxicol"},{"key":"497_CR70","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/tera.1420210203","volume":"21","author":"SM Barlow","year":"1980","unstructured":"Barlow SM, Knight AF, Sullivan FM (1980) Diazepam-induced cleft palate in the mouse: the role of endogenous maternal corticosterone. Teratology 21:149\u2013155","journal-title":"Teratology"},{"key":"497_CR71","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/tera.1420270209","volume":"27","author":"S Prahalada","year":"1983","unstructured":"Prahalada S, Hendrickx AG (1983) Embryotoxicity of Norlestrin, a combined synthetic oral contraceptive, in rhesus macaques (Macaca mulatta). Teratology 27:215\u2013222","journal-title":"Teratology"},{"key":"497_CR72","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/tera.1420300205","volume":"30","author":"R Tarara","year":"1984","unstructured":"Tarara R (1984) The effect of medroxyprogesterone acetate (Depo-Provera) on prenatal development in the baboon (Papio anubis): a preliminary study. Teratology 30:181\u2013185","journal-title":"Teratology"},{"key":"497_CR73","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/tera.1420320312","volume":"32","author":"S Prahalada","year":"1985","unstructured":"Prahalada S, Carroad E, Cukierski M, Hendrickx AG (1985) Embryotoxicity of a single dose of medroxyprogesterone acetate (MPA) and maternal serum MPA concentrations in cynomolgus monkey (Macaca fascicularis). Teratology 32:421\u2013432","journal-title":"Teratology"},{"key":"497_CR74","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/tera.1420350115","volume":"35","author":"A Poggel","year":"1987","unstructured":"Poggel A, Hendrickx AG, Korte R, Leuschner F, Neumann BW, Prahalada S, Binkerd PE, Gunzel P (1987) Embryotoxicity of sex steroidal hormone combinations in nonhuman primates: I. Norethisterone acetate\u00a0+\u00a0ethinylestradiol and progesterone\u00a0+\u00a0estradiol benzoate (Macaca mulatta, Macaca fascicularis, and Papio cynocephalus). Teratology 35:119\u2013127","journal-title":"Teratology"},{"key":"497_CR75","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/tera.1420420203","volume":"42","author":"JP Carbone","year":"1990","unstructured":"Carbone JP, Figurska K, Buck S, Brent RL (1990) Effect of gestational sex steroid exposure on limb development and endochondral ossification in the pregnant C57Bl\/6J mouse: I. Medroxyprogesterone acetate. Teratology 42:121\u2013130","journal-title":"Teratology"},{"key":"497_CR76","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/0002-9378(93)90296-U","volume":"169","author":"JP Carbone","year":"1993","unstructured":"Carbone JP, Brent RL (1993) Genital and non genital teratogenesis of prenatal progestogen therapy: the effects of 17 alpha-hydroxyprogesterone caproate on embryonic and fetal development and endochondral ossification in the C57B1\/6J mouse. Am J Obstet Gynecol 169:1292\u20131298","journal-title":"Am J Obstet Gynecol"},{"key":"497_CR77","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0010-7824(94)90037-X","volume":"49","author":"A Jordan","year":"1994","unstructured":"Jordan A (1994) Toxicology of depot medroxyprogesterone acetate. Contraception 49:189\u2013201","journal-title":"Contraception"},{"key":"497_CR78","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0027-5107(75)90205-5","volume":"33","author":"N Bishun","year":"1975","unstructured":"Bishun N, Mills J, Parke JV, Williams DC (1975) A cytogenetic study in women who had used oral contraceptives and in their progeny. Mutat Res 33:299\u2013310","journal-title":"Mutat Res"},{"key":"497_CR79","first-page":"40","volume":"48","author":"HP Klinger","year":"1976","unstructured":"Klinger HP, Glasser M, Kava HW (1976) Contraceptives and the conceptus. I. Chromosome abnormalities of the fetus and neonate related to maternal contraceptive history. Obstet Gynecol 48:40\u201348","journal-title":"Obstet Gynecol"},{"key":"497_CR80","first-page":"125","volume":"51","author":"R Muller","year":"1978","unstructured":"Muller R, Ritter C (1978) Cytogenetic studies on women during and following the use of hormonal contraceptives. Zentralbl Gynakol 51:125\u2013129","journal-title":"Zentralbl Gynakol"},{"key":"497_CR81","first-page":"183","volume":"13","author":"ZH Tu","year":"1992","unstructured":"Tu ZH, Wang MY, Qi XD, Xu WB, Xu DH (1992) Lack of mutagenicity and teratogenicity of 16-methylene\u201317-alpha-acetoxy-19-norprogesterone. Zhongguo Yao Li Xue Bao 13:183\u2013186","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"497_CR82","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0165-1218(93)90053-G","volume":"300","author":"SK Shyama","year":"1993","unstructured":"Shyama SK, Abdul Rahiman M (1993) Progestin (norethisterone)-induced genetic damage in mouse bone marrow. Mutat Res 300:215\u2013221","journal-title":"Mutat Res"},{"key":"497_CR83","first-page":"311","volume":"45","author":"R Herzog","year":"1995","unstructured":"Herzog R, Leuschner J, Henning (1995) Evaluation of the mutagenicity of medroxyprogesterone acetate in vitro and in vivo. Arzneimittelforschung 45:311\u2013314","journal-title":"Arzneimittelforschung"},{"key":"497_CR84","first-page":"293","volume":"61","author":"C Lanari","year":"2001","unstructured":"Lanari C, Luthy I, Lamb CA, Fabris V, Pagano E, Helguero LA, Sanjuan N, Merani S, Molinolo AA (2001) Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins. Cancer Res 61:293\u2013302","journal-title":"Cancer Res"},{"key":"497_CR85","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1383-5742(02)00047-9","volume":"512","author":"B Giovanni","year":"2002","unstructured":"Giovanni B, Martelli A (2002) Are some progestins genotoxic liver carcinogens? Mutation Research 512:155\u2013163","journal-title":"Mutation Research"},{"key":"497_CR86","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0010-7824(80)90021-9","volume":"22","author":"J Kremer","year":"1980","unstructured":"Kremer J, de Bruijn HW, Hindriks FR (1980) Serum high density lipoprotein cholesterol levels in women using a contraceptive injection of depot-medroxyprogesterone acetate. Contraception 22:359\u2013367","journal-title":"Contraception"},{"key":"497_CR87","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000299042","volume":"18","author":"N Crona","year":"1983","unstructured":"Crona N, Enk L, Friberg LG, Samsioe G, Silfverstolpe G (1983) Changes in apolipoprotein AI after treatment with high-dose medroxyprogesterone acetate. Gynecol Obstet Invest 18:16\u201320","journal-title":"Gynecol Obstet Invest"},{"key":"497_CR88","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0021-9150(83)90077-1","volume":"47","author":"M Gronroos","year":"1983","unstructured":"Gronroos M, Lehtonen A (1983) Effect of high dose progestin on serum lipids. Atherosclerosis 47:101\u2013105","journal-title":"Atherosclerosis"},{"key":"497_CR89","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0010-7824(85)90074-5","volume":"31","author":"DF Liew","year":"1985","unstructured":"Liew DF, Ng CS, Yong YM, Ratnam SS (1985) Long-term effects of Depo-Provera on carbohydrate and lipid metabolism. Contraception 31:51\u201364","journal-title":"Contraception"},{"key":"497_CR90","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0090-8258(85)90046-0","volume":"22","author":"L Enk","year":"1985","unstructured":"Enk L, Crona N, Friberg LG, Samsioe G, Silfverstolpe G (1985) High-dose depot-medroxyprogesterone acetate\u2014effects on the fatty acid composition of serum lecithin and cholesterol ester. Gynecol Oncol 22:317\u2013323","journal-title":"Gynecol Oncol"},{"key":"497_CR91","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0015-0282(16)49277-0","volume":"45","author":"L Fahraeus","year":"1986","unstructured":"Fahraeus L, Sydsjo A, Wallentin L (1986) Lipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate. Fertil Steril 45:503\u2013506","journal-title":"Fertil Steril"},{"key":"497_CR92","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0010-7824(90)90127-H","volume":"41","author":"EM Wallace","year":"1990","unstructured":"Wallace EM, Wu FCW (1990) Effect of medroxyprogesterone acetate and testosterone oenanthate on serum lipoproteins in man. Contraception 41:63\u201371","journal-title":"Contraception"},{"key":"497_CR93","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0010-7824(91)90106-P","volume":"44","author":"J Garza-Flores","year":"1991","unstructured":"Garza-Flores J, De la Cruz DL, Valles de Bourges V, Sanchez-Nuncio R, Martinez M, Fuziwara JL, Perez-Palacios G (1991) Long-term effects of depot-medroxyprogesterone acetate on lipoprotein metabolism. Contraception 44:61\u201371","journal-title":"Contraception"},{"key":"497_CR94","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2007-1003262","volume":"24","author":"L Enk","year":"1992","unstructured":"Enk L, Landgren BM, Lindberg UB, Silfverstolpe G, Crona N (1992) A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids. Horm Metab Res 24:85\u201389","journal-title":"Horm Metab Res"},{"key":"497_CR95","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0010-7824(93)90090-T","volume":"47","author":"R Kongsayreepong","year":"1993","unstructured":"Kongsayreepong R, Chutivongse S, George P, Joyce S, McCone JM, Garza-Flores J, Valles de Bourges V, Cruz DL, Perez-Palacios G, Rosseneu M (1993) A multicentre comparative study of serum lipids and apolipoproteins in long-term users of DMPA and a control group of IUD users. Contraception 47:177\u2013191","journal-title":"Contraception"},{"key":"497_CR96","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/jrf.0.0680137","volume":"68","author":"BG Miller","year":"1983","unstructured":"Miller BG, Moore NW (1983) Endometrial protein secretion during early pregnancy in entire and ovariectomized ewes. J Reprod Fertil 68:137\u2013144","journal-title":"J Reprod Fertil"},{"key":"497_CR97","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.contraception.2003.09.015","volume":"69","author":"TE Canto Cetina de","year":"2004","unstructured":"Canto de Cetina TE, Luna MO, Cetina Canto JA, Bassol S (2004) Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200\u00a0mg) as contraceptive injections. Contraception 69:115\u2013119","journal-title":"Contraception"},{"key":"497_CR98","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1620\/tjem.205.79","volume":"205","author":"A Topcuoglu","year":"2005","unstructured":"Topcuoglu A, Uzun H, Aydin S, Kahraman N, Vehid S, Zeybek G, Topcuoglu D (2005) The effect of hormone replacement therapy on oxidized low density lipoprotein levels and paraoxonase activity in postmenopausal women. Tohoku J Exp Med 205:79\u201386","journal-title":"Tohoku J Exp Med"},{"key":"497_CR99","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02889898","volume":"50","author":"W Bursch","year":"1985","unstructured":"Bursch W, Taper HS, Lauer B, Schulte-Hermann R (1985) Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia. Virchows Arch B Cell Pathol Incl Mol Pathol 50:153\u2013166","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"497_CR100","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/carcin\/17.7.1473","volume":"17","author":"MJ Tucker","year":"1996","unstructured":"Tucker MJ, Kalinowski AE, Orton TC (1996) Carcinogenicity of cyproterone acetate in the mouse. Carcinogenesis,l 17:1473\u20131476","journal-title":"Carcinogenesis,l"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-007-0497-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-007-0497-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-007-0497-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T06:49:51Z","timestamp":1684392591000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-007-0497-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,10]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["497"],"URL":"https:\/\/doi.org\/10.1007\/s00404-007-0497-z","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,10]]}}}